We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common use of In case of Blinding the Clinical Trial; Use of Randomization Codes Clause in Contracts

In case of Blinding the Clinical Trial; Use of Randomization Codes. The Principal Investigator conducting a blinded study agrees to maintain the blinding of the Study Product. The Principal Investigator understands that the randomization codes will be released upon completion of the Clinical Trial and finalization of the database by Xxxxxxx. For multi-center studies, data from all centers are required before the Clinical Trial is considered complete. Should a medical emergency occur requiring the Principal Investigator to break the code for a specific subject, the Principal Investigator agrees to notify Janssen immediately.

Appears in 4 contracts

Samples: Clinical Trial Agreement, Clinical Trial Agreement, Clinical Trial Agreement

In case of Blinding the Clinical Trial; Use of Randomization Codes. The Principal Investigator conducting a blinded study agrees to maintain the blinding of the Study Product. The Principal Investigator understands that the randomization codes will be released upon completion of the Clinical Trial and finalization of the database by Xxxxxxx. For multi-center studies, data from all centers are required before the Clinical Trial is considered complete. Should a medical emergency occur requiring the Principal Investigator to break the code for a specific subject, the Principal Investigator agrees to notify Janssen immediately.

Appears in 1 contract

Samples: Clinical Trial Agreement

In case of Blinding the Clinical Trial; Use of Randomization Codes. The Principal Investigator conducting a blinded study agrees to maintain the blinding of the Study Product. The Principal Investigator understands that the randomization codes will be released upon completion of the Clinical Trial and finalization of the database by XxxxxxxJanssen. For multi-center studies, data from all centers are required before the Clinical Trial is considered complete. Should a medical emergency occur requiring the Principal Investigator to break the code for a specific subject, the Principal Investigator agrees to notify Janssen immediately.

Appears in 1 contract

Samples: Clinical Trial Agreement